MEDTECH INDUSTRY INVITED TO NSW PARLIAMENT HOUSE Local manufacturing emerges as key priority, along with jobs, supply chain resilience and patient benefits
With
Justin Foster,
Associate Director, Advocacy and Government Relations,
Medical Technology Association of Australia
Brendan Cummins
VP & General Manager ANZ,
Baxter Healthcare
The Hon Courtney Houssos MLC, Minister for Finance,
Minister for Domestic Manufacturing and Government Procurement,
Minister for Natural Resources, NSW Parliament
James Doyle, Vice-Chair
Medical Technology Association of Australia (MTAA)
Lachlan Thorpe, Age 21
Diagnosed with CRPS following sporting injury, recipient of spinal cord stimulator
SEGMENT
Filmed in Sydney | August 2026
The inaugural NSW Parliament MedTech Showcase, hosted by The Hon Courtney Houssos MLC has highlighted the medical technology sector’s contribution to patient care, local manufacturing, jobs and the broader economy.
Speaking with the Australian Health Journal, Justin Foster, Associate Director of Advocacy and Government Relations at the Medical Technology Association of Australia (MTAA), said the event provided an important opportunity for industry and government to work together on shared priorities.
He said the showcase demonstrated that MedTech not only saves and improves lives, but also creates significant economic opportunities through manufacturing, investment, exports and employment. “We’re collaborating with them on a unity ticket in terms of delivering more value to the economy, manufacturing, and also to local jobs,” Foster said.
The event brought together a diverse range of companies, from emerging startups and small and medium-sized businesses to global MedTech companies investing in NSW. The showcase also demonstrated the importance of sovereign manufacturing capability, particularly during supply disruptions.
The message was local production could strengthen supply chains while supporting highly skilled employment and innovation. The event also provided an opportunity for the industry to discuss policy issues, including value-based procurement, which seeks to ensure purchasing decisions consider the broader value of medical technologies rather than price alone.
Foster said the showcase could serve as a model for further engagement across Australia. “There is definitely an opportunity for us to be engaging across states and territories,” with future discussions potentially extending the initiative beyond NSW.
Source: Written by Australian Health Journal from transcript.
-
The role of genomic screening in transforming public health
Dr Jane Tiller is a lawyer, genetic counsellor and public health researcher. She is Ethical, Legal & Social Adviser in Public Health Genomics at Monash University, and a National Health and Medical Research Council Investigator Grant holder. Jane is passionate about the use of genomics to prevent disease, and in delivering equitable access to preventive genetic information at the population level. She is co-lead of DNA Screen, a world-first study piloting the offer of preventive DNA screening to the Australian adult population. DNA Screen has tested over 10,000 young people for genetic high risk of medically actionable conditions such as cancer and heart disease, finding about 2% of participants had genetic high risk. Jane is leading efforts to secure Commonwealth Government funding to expand the DNA Screen program, with the eventual goal of the development of a public health population screening program for disease prevention based on high genetic risk.
-
Medicinal cannabis in Australia Update
According to the Australian Journal of General Practice, published by the Royal Australian College of General Practitioners, more than 130,000 medicinal cannabis approvals have been issued in Australia to date, mostly by general practitioners, with approximately 65% of these to treat chronic non-cancer pain. Despite robust supportive data from animal models, current clinical trial evidence for THC and CBD efficacy in chronic pain is incomplete. In their prescribing decisions, doctors must balance patient demand and curiosity with caution regarding potential risks and limited efficacy.
Australian Health Journal met with 3 speakers at the recent ARCS22 Conference providing an update on medicinal cannabis. The discussion with the speakers now centres on affordability and access.
-
App helps Chronic Sleep Deprivation
Earlier this year, Turner Institute for Brain and Mental Health researchers developed SleepSync, the world’s first app that personalises sleep-wake cycles for shift workers to improve their sleep and overall mood.
The research, led by Dr Jade Murray, was published in the journal, Digital Health. Australian Health Journal met with Dr Murray to hear how the application has evolved and been used in personalisation of sleep habits for health care shift workforce.
